BGM Group (BGM) Competitors $10.95 +1.10 (+11.17%) Closing price 04:00 PM EasternExtended Trading$10.96 +0.01 (+0.05%) As of 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock BGM vs. KYMR, HCM, MOR, ALVO, AMRX, RARE, MIRM, CPRX, OGN, and ARWRShould you be buying BGM Group stock or one of its competitors? The main competitors of BGM Group include Kymera Therapeutics (KYMR), HUTCHMED (HCM), MorphoSys (MOR), Alvotech (ALVO), Amneal Pharmaceuticals (AMRX), Ultragenyx Pharmaceutical (RARE), Mirum Pharmaceuticals (MIRM), Catalyst Pharmaceuticals (CPRX), Organon & Co. (OGN), and Arrowhead Pharmaceuticals (ARWR). These companies are all part of the "pharmaceutical products" industry. BGM Group vs. Its Competitors Kymera Therapeutics HUTCHMED MorphoSys Alvotech Amneal Pharmaceuticals Ultragenyx Pharmaceutical Mirum Pharmaceuticals Catalyst Pharmaceuticals Organon & Co. Arrowhead Pharmaceuticals Kymera Therapeutics (NASDAQ:KYMR) and BGM Group (NASDAQ:BGM) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations. Which has more volatility and risk, KYMR or BGM? Kymera Therapeutics has a beta of 2.18, suggesting that its share price is 118% more volatile than the S&P 500. Comparatively, BGM Group has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Does the media favor KYMR or BGM? In the previous week, Kymera Therapeutics had 3 more articles in the media than BGM Group. MarketBeat recorded 5 mentions for Kymera Therapeutics and 2 mentions for BGM Group. Kymera Therapeutics' average media sentiment score of 0.76 beat BGM Group's score of 0.00 indicating that Kymera Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kymera Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BGM Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate KYMR or BGM? Kymera Therapeutics currently has a consensus target price of $59.11, suggesting a potential upside of 28.92%. Given Kymera Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Kymera Therapeutics is more favorable than BGM Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kymera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 17 Buy rating(s) 2 Strong Buy rating(s) 3.05BGM Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings and valuation, KYMR or BGM? BGM Group has lower revenue, but higher earnings than Kymera Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKymera Therapeutics$47.07M63.43-$223.86M-$3.10-14.79BGM Group$25.10M42.41-$1.44MN/AN/A Is KYMR or BGM more profitable? BGM Group has a net margin of 0.00% compared to Kymera Therapeutics' net margin of -409.07%. BGM Group's return on equity of 0.00% beat Kymera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Kymera Therapeutics-409.07% -30.11% -25.65% BGM Group N/A N/A N/A SummaryKymera Therapeutics beats BGM Group on 9 of the 13 factors compared between the two stocks. Get BGM Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricBGM GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.06B$3.06B$5.67B$9.49BDividend YieldN/A2.44%4.05%4.00%P/E RatioN/A20.8627.9419.95Price / Sales42.41246.06396.5882.68Price / CashN/A41.9636.1958.45Price / Book1.498.308.635.82Net Income-$1.44M-$55.19M$3.24B$258.42M7 Day Performance13.47%5.07%3.22%1.94%1 Month Performance-15.18%17.61%10.72%12.02%1 Year PerformanceN/A7.03%34.94%20.80% BGM Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGMBGM GroupN/A$10.95+11.2%N/AN/A$1.06B$25.10M0.00298News CoverageGap UpHigh Trading VolumeKYMRKymera Therapeutics3.1557 of 5 stars$44.31-1.3%$59.11+33.4%+6.8%$2.88B$47.07M-14.25170HCMHUTCHMED2.8081 of 5 stars$16.38+0.9%$19.00+16.0%-7.0%$2.86B$630.20M0.001,811Analyst ForecastMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730ALVOAlvotech2.8765 of 5 stars$8.84-0.7%$18.00+103.7%-22.4%$2.65B$585.60M23.751,032High Trading VolumeAMRXAmneal Pharmaceuticals3.2932 of 5 stars$8.38-0.4%$11.60+38.4%+8.6%$2.62B$2.79B-209.328,100RAREUltragenyx Pharmaceutical4.3494 of 5 stars$27.77-5.0%$83.64+201.3%-38.0%$2.62B$560.23M-4.721,294Upcoming EarningsMIRMMirum Pharmaceuticals3.9526 of 5 stars$52.03-2.4%$65.50+25.9%+32.0%$2.58B$336.89M-32.36140Positive NewsCPRXCatalyst Pharmaceuticals4.9136 of 5 stars$21.05-2.6%$32.83+56.0%+22.8%$2.56B$491.73M13.3980News CoveragePositive NewsOGNOrganon & Co.4.8521 of 5 stars$9.66-1.5%$18.00+86.4%-53.0%$2.51B$6.40B3.354,000ARWRArrowhead Pharmaceuticals3.879 of 5 stars$18.12-2.6%$43.71+141.2%-44.7%$2.50B$545.21M-12.94400Positive News Related Companies and Tools Related Companies KYMR Competitors HCM Competitors MOR Competitors ALVO Competitors AMRX Competitors RARE Competitors MIRM Competitors CPRX Competitors OGN Competitors ARWR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGM) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BGM Group Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BGM Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
